Genevieve L. Wojcik,Mariaelisa Graff,Katherine K. Nishimura,Ran Tao,Jeffrey Haessler,Christopher R. Gignoux,Heather M. Highland,Yesha M. Patel,Elena P. Sorokin,Christy L. Avery,Gillian M. Belbin,Stephanie A. Bien,Iona Cheng,Sinead Cullina,Chani J. Hodonsky,Yao Hu,Laura M. Huckins,Janina Jeff,Anne E. Justice,Jonathan M. Kocarnik,Unhee Lim,Bridget M. Lin,Yingchang Lu,Sarah C. Nelson,Sung-Shim L. Park,Hannah Poisner,Michael H. Preuss,Melissa A. Richard,Claudia Schurmann,Veronica W. Setiawan,Alexandra Sockell,Karan Vahi,Marie Verbanck,Abhishek Vishnu,Ryan W. Walker,Kristin L. Young,Niha Zubair,Victor Acuña-Alonso,Jose Luis Ambite,Kathleen C. Barnes,Eric Boerwinkle,Erwin P. Bottinger,Carlos D. Bustamante,Christian Caberto,Samuel Canizales-Quinteros,Matthew P. Conomos,Ewa Deelman,Ron Do,Kimberly Doheny,Lindsay Fernández-Rhodes,Myriam Fornage,Benyam Hailu,Gerardo Heiss,Brenna M. Henn,Lucia A. Hindorff,Rebecca D. Jackson,Cecelia A. Laurie,Cathy C. Laurie,Yuqing Li,Dan-Yu Lin,Andres Moreno-Estrada,Girish Nadkarni,Paul J. Norman,Loreall C. Pooler,Alexander P. Reiner,Jane Romm,Chiara Sabatti,Karla Sandoval,Xin Sheng,Eli A. Stahl,Daniel O. Stram,Timothy A. Thornton,Christina L. Wassel,Lynne R. Wilkens,Cheryl A. Winkler,Sachi Yoneyama,Steven Buyske,Christopher A. Haiman,Charles Kooperberg,Loic Le Marchand,Ruth J. F. Loos,Tara C. Matise,Kari E. North,Ulrike Peters,Eimear E. Kenny,Christopher S. Carlson

Abstract:Genome-wide association studies (GWAS) have laid the foundation for investigations into the biology of complex traits, drug development and clinical guidelines. However, the majority of discovery efforts are based on data from populations of European ancestry<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="/articles/s41586-019-1310-4#ref-CR3">3</a>. In light of the differential genetic architecture that is known to exist between populations, bias in representation can exacerbate existing disease and healthcare disparities. Critical variants may be missed if they have a low frequency or are completely absent in European populations, especially as the field shifts its attention towards rare variants, which are more likely to be population-specific<a href="#ref-CR4">4</a>,<a href="#ref-CR5">5</a>,<a href="#ref-CR6">6</a>,<a href="#ref-CR7">7</a>,<a href="#ref-CR8">8</a>,<a href="#ref-CR9">9</a>,<a href="/articles/s41586-019-1310-4#ref-CR10">10</a>. Additionally, effect sizes and their derived risk prediction scores derived in one population may not accurately extrapolate to other populations<a href="/articles/s41586-019-1310-4#ref-CR11">11</a>,<a href="/articles/s41586-019-1310-4#ref-CR12">12</a>. Here we demonstrate the value of diverse, multi-ethnic participants in large-scale genomic studies. The Population Architecture using Genomics and Epidemiology (PAGE) study conducted a GWAS of 26 clinical and behavioural phenotypes in 49,839 non-European individuals. Using strategies tailored for analysis of multi-ethnic and admixed populations, we describe a framework for analysing diverse populations, identify 27 novel loci and 38 secondary signals at known loci, as well as replicate 1,444 GWAS catalogue associations across these traits. Our data show evidence of effect-size heterogeneity across ancestries for published GWAS associations, substantial benefits for fine-mapping using diverse cohorts and insights into clinical implications. In the United States—where minority populations have a disproportionately higher burden of chronic conditions<a href="/articles/s41586-019-1310-4#ref-CR13">13</a>—the lack of representation of diverse populations in genetic research will result in inequitable access to precision medicine for those with the highest burden of disease. We strongly advocate for continued, large genome-wide efforts in diverse populations to maximize genetic discovery and reduce health disparities.

Reproducible brain-wide association studies require thousands of individuals

Replicable brain-phenotype associations require large-scale neuroimaging data

Bias in data-driven estimates of the reproducibility of univariate brain-wide association studies.

Study design features increase replicability in brain-wide association studies

Study design features increase replicability in cross-sectional and longitudinal brain-wide association studies

Design tips for reproducible studies linking the brain to behaviour

Replicability and generalizability in population psychiatric neuroimaging

Small effect size leads to reproducibility failure in resting-state fMRI studies

Leveraging the adolescent brain cognitive development study to improve behavioral prediction from neuroimaging in smaller replication samples

Reproducibility in the Absence of Selective Reporting: an Illustration from Large-Scale Brain Asymmetry Research

An illustration of reproducibility in neuroscience research in the absence of selective reporting

On the replicability of diffusion weighted MRI-based brain-behavior models

Scanning the horizon: towards transparent and reproducible neuroimaging research

Power and reproducibility in the external validation of brain-phenotype predictions

MRI economics: Balancing sample size and scan duration in brain wide association studies

The Burden of Reliability: How Measurement Noise Limits Brain-Behaviour Predictions

Genome-wide association studies of brain imaging phenotypes in UK Biobank

Single-nucleus transcriptome-wide association study of human brain disorders

Assessing Overall Reproducibility for Large-scale High-throughput MRI-based Association Studies

Genetic analyses of diverse populations improves discovery for complex traits

Accelerating Heritability, Genetic Correlation, and Genome‐Wide Association Imaging Genetic Analyses in Complex Pedigrees